ARTICLE | Clinical News
Amiscan: Began Phase II trial
February 20, 2001 8:00 AM UTC
Draxis Health Inc. (DRAX; TSE:DAX), Mississauga, Ontario Product: Amiscan Business: Diagnostics/Imaging Therapeutic category: Imaging agent Target: NA Description: Technetium-labeled D-glucaric acid ...